news roundup
Certara announced that the Brazilian National Health Surveillance Agency, ANVISA is now also employing Certara’s Phoenix WinNonlin software for reviewing drug regulatory submissions.
| advertisment
Considerations for Efficient Site Contracts and Payments
Clinical trial agreement development has a tremendous impact on study start-up – integrating site-level budgets, payment terms, and Clinical Trial Management Systems set-up. By understanding the most important considerations for contract development and budget planning, you can execute a fully-integrated process that results in high-efficiency enabled contracts and payments.
 Download the White Paper |
Updated employee announcements, business news, awards, and recognition in the industry today.
A collaborative, solutions-driven partnership, featuring end-to-end support of clinical trials is now underway between Celerion and OmniComm Systems, Inc.
| advertisment
The Benefits of a Data-driven Approach to Feasibility
Live Webcast: Tuesday, March 20 at 11:00am EDT
 Register now |
With the combination of Compleware’s eClinical software and service solutions along with YPrime’s collection of clinical data and their IRT offering which manages clinical systems, they have announced a partnership agreement to deliver enhanced service offerings.
| |
|
advertisment
|
|
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
|
Articles
Today, a data-driven approach to feasibility assessment can help ensure that a sponsor’s clinical research plan is designed to enroll the right patients, rely on the right investigators, and take place in the right countries for success.
| advertisment
The Rare Disease Revolution
Live Webcast: Thursday, January 25 11:00am EST
 Register now |
Examining the main challenges in designing and executing MS clinical trials and proposing mitigation strategies that may help alleviate these burdens.
|
|
Blog Posts
In this interview, Christa Polidori, Clinical Trial Disclosure Manager at Bristol-Myers Squibb and a leader for the TransCelerate Clinical Research Access and Information Exchange Initiative, will discuss the TransCelerate proposal in greater detail.
| advertisment
Research Reveals a Need for Evolution in Randomization and Trial Supply Management (RTSM) Technology
On Demand
 Learn more |
Kristy Galante recently spoke about a novel vendor oversight model at ExL’s 8th Clinical Quality Oversight Forum, and will expand on the model in this interview.
|
|
RBM
Sponsors and CROs are looking into implementation of a Risk Based Monitoring approach to their clinical trials to achieve the objectives related to enhanced data quality, better monitoring of patient safety, and creating efficiencies in overall operations.
|
|
Steve Young looks at the tremendous benefits that organizations stand to reap by effectively implementing the core principles included in the ICH update and the significant opportunities that the application of intelligent analytics and centralized statistical monitoring may present.
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|
